813MO Efficacy of subsequent chemotherapy for patients with BRCA1/2 mutated platinum-sensitive recurrent epithelial ovarian cancer (EOC) progressing on olaparib vs placebo: The SOLO2/ENGOT Ov-21 trial.
Saved in:
| Title: | 813MO Efficacy of subsequent chemotherapy for patients with BRCA1/2 mutated platinum-sensitive recurrent epithelial ovarian cancer (EOC) progressing on olaparib vs placebo: The SOLO2/ENGOT Ov-21 trial. |
|---|---|
| Authors: | Frenel, J-S.1 (AUTHOR), Kim, J-W.2 (AUTHOR), Berton-Rigaud, D.1 (AUTHOR), Asher, R.3 (AUTHOR), Vidal, L.4 (AUTHOR), Pautier, P.5 (AUTHOR), Ledermann, J.A.6 (AUTHOR), Penson, R.T.7 (AUTHOR), Oza, A.M.8 (AUTHOR), Korach, J.9 (AUTHOR), Huzarski, T.10 (AUTHOR), Pignata, S.11 (AUTHOR), Colombo, N.12 (AUTHOR), Park-Simon, T-W.13 (AUTHOR), Tamura, K.14 (AUTHOR), Sonke, G.S.15 (AUTHOR), Freimund, A.16 (AUTHOR), Lee, C.K.17 (AUTHOR), Pujade-Lauraine, E.18 (AUTHOR) |
| Source: | Annals of Oncology. 2020 Supplement 4, Vol. 31, pS615-S615. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152695487 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 813MO Efficacy of subsequent chemotherapy for patients with BRCA1/2 mutated platinum-sensitive recurrent epithelial ovarian cancer (EOC) progressing on olaparib vs placebo: The SOLO2/ENGOT Ov-21 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Frenel%2C+J-S%2E%22">Frenel, J-S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+J-W%2E%22">Kim, J-W.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Berton-Rigaud%2C+D%2E%22">Berton-Rigaud, D.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Asher%2C+R%2E%22">Asher, R.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vidal%2C+L%2E%22">Vidal, L.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pautier%2C+P%2E%22">Pautier, P.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ledermann%2C+J%2EA%2E%22">Ledermann, J.A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Penson%2C+R%2ET%2E%22">Penson, R.T.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oza%2C+A%2EM%2E%22">Oza, A.M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Korach%2C+J%2E%22">Korach, J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huzarski%2C+T%2E%22">Huzarski, T.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pignata%2C+S%2E%22">Pignata, S.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Colombo%2C+N%2E%22">Colombo, N.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Park-Simon%2C+T-W%2E%22">Park-Simon, T-W.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tamura%2C+K%2E%22">Tamura, K.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sonke%2C+G%2ES%2E%22">Sonke, G.S.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Freimund%2C+A%2E%22">Freimund, A.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+C%2EK%2E%22">Lee, C.K.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pujade-Lauraine%2C+E%2E%22">Pujade-Lauraine, E.</searchLink><relatesTo>18</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 4, Vol. 31, pS615-S615. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152695487 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2020.08.952 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S615 Titles: – TitleFull: 813MO Efficacy of subsequent chemotherapy for patients with BRCA1/2 mutated platinum-sensitive recurrent epithelial ovarian cancer (EOC) progressing on olaparib vs placebo: The SOLO2/ENGOT Ov-21 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Frenel, J-S. – PersonEntity: Name: NameFull: Kim, J-W. – PersonEntity: Name: NameFull: Berton-Rigaud, D. – PersonEntity: Name: NameFull: Asher, R. – PersonEntity: Name: NameFull: Vidal, L. – PersonEntity: Name: NameFull: Pautier, P. – PersonEntity: Name: NameFull: Ledermann, J.A. – PersonEntity: Name: NameFull: Penson, R.T. – PersonEntity: Name: NameFull: Oza, A.M. – PersonEntity: Name: NameFull: Korach, J. – PersonEntity: Name: NameFull: Huzarski, T. – PersonEntity: Name: NameFull: Pignata, S. – PersonEntity: Name: NameFull: Colombo, N. – PersonEntity: Name: NameFull: Park-Simon, T-W. – PersonEntity: Name: NameFull: Tamura, K. – PersonEntity: Name: NameFull: Sonke, G.S. – PersonEntity: Name: NameFull: Freimund, A. – PersonEntity: Name: NameFull: Lee, C.K. – PersonEntity: Name: NameFull: Pujade-Lauraine, E. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2020 Supplement 4 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 31 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
